Table 1 Characteristics of patients.

From: Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Characteristics

Patients (%)

Age (y)

 Median

65

 Range

36–74

Performance status (ECOG)

 0–1

355 (69%)

 ≥2

162 (31%)

Tumor length (cm)

 Median

4

 Range

2–12

Location

 Proximal third

44 (9%)

 Middle third

384 (74%)

 Distal third

89 (17%)

Stage

 II

83 (16%)

 III

377 (73%)

 IV

57 (11%)

Radiotherapy dose (Gy)

 Median

50

 Range

50–60

Chemotherapy cycle

 Median

2

 Range

2–6